These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 17205431)

  • 1. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
    Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatitis A in Italy: incidence, risk factors and preventive measures.
    Tosti ME; Spada E; Romanò L; Zanetti A; Mele A;
    J Viral Hepat; 2008 Oct; 15 Suppl 2():26-32. PubMed ID: 18837830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
    Mele A; Stroffolini T; Zanetti AR
    J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for and incidence of acute hepatitis C after the achievement of blood supply safety in Italy: results from the national surveillance system.
    Spada E; Mele A; Mariano A; Zuccaro O; Tosti ME;
    J Med Virol; 2013 Mar; 85(3):433-40. PubMed ID: 23280786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline of incidence of A, B and non-A, non-B hepatitis in Italy. Results of four years surveillance (1985-88). SEIEVA collaborating group.
    Mele A; Stazi MA; Corona R; Ferrigno L; Sagliocca L; Palumbo F; Falasca P; Galanti C; Moiraghi A; Rosmini F
    Ital J Gastroenterol; 1990 Oct; 22(5):274-80. PubMed ID: 2134326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of endemic viral hepatitis in an urban area of India: a retrospective community study in Alwar.
    Singh J; Prakash C; Gupta RS; Bora D; Jain DC; Datta KK
    Bull World Health Organ; 1997; 75(5):463-8. PubMed ID: 9447780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.
    Goldstein ST; Alter MJ; Williams IT; Moyer LA; Judson FN; Mottram K; Fleenor M; Ryder PL; Margolis HS
    J Infect Dis; 2002 Mar; 185(6):713-9. PubMed ID: 11920288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.
    Salleras L; Domínguez A; Bruguera M; Plans P; Costa J; Cardeñosa N; Batalla J; Plasència A
    Vaccine; 2007 Dec; 25(52):8726-31. PubMed ID: 18045753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
    Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
    Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States.
    Mahoney FJ; Stewart K; Hu H; Coleman P; Alter MJ
    Arch Intern Med; 1997 Dec 8-22; 157(22):2601-5. PubMed ID: 9531229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H
    J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
    Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
    Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing hepatitis B vaccination coverage among healthcare workers in Italy 10 years apart.
    Stroffolini T; Coppola R; Carvelli C; D'Angelo T; De Masi S; Maffei C; Marzolini F; Ragni P; Cotichini R; Zotti C; Mele A
    Dig Liver Dis; 2008 Apr; 40(4):275-7. PubMed ID: 18083081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy.
    Bhimma R; Coovadia HM; Adhikari M; Connolly CA
    Arch Pediatr Adolesc Med; 2003 Oct; 157(10):1025-30. PubMed ID: 14557165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination.
    Perz JF; Elm JL; Fiore AE; Huggler JI; Kuhnert WL; Effler PV
    Pediatrics; 2006 Oct; 118(4):1403-8. PubMed ID: 17015529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.